Publication | Open Access
Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis
42
Citations
29
References
2017
Year
NCT01721057; Results.
| Year | Citations | |
|---|---|---|
Page 1
Page 1